A PHASE II STUDY EVALUATING THE ROLE OF ANDROGEN RECEPTORS AS TARGETS FOR THERAPY OF PRE-TREATED POST-MENOPAUSAL PATIENTS WITH ER/PGR-NEGATIVE/AR-POSITIVE OR ER AND/OR PGRPOSITIVE/ AR-POSITIVE METASTATIC BREAST CANCER (ARTT):